These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20203479)

  • 1. Genetic screening in Europe.
    Javaher P; Nyoungui E; Kääriäinen H; Kristoffersson U; Nippert I; Sequeiros J; Schmidtke J
    Public Health Genomics; 2010; 13(7-8):524-37. PubMed ID: 20203479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic screening and ethics: European perspectives.
    Chadwick R; ten Have H; Husted J; Levitt M; McGleenan T; Shickle D; Wiesing U
    J Med Philos; 1998 Jun; 23(3):255-73. PubMed ID: 9736188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population genetic screening programmes: principles, techniques, practices, and policies.
    Godard B; ten Kate L; Evers-Kiebooms G; Aymé S
    Eur J Hum Genet; 2003 Dec; 11 Suppl 2():S49-87. PubMed ID: 14718938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EuroGentest: DNA-based testing for heritable disorders in Europe.
    Javaher P; Kaariainen H; Kristoffersson U; Nippert I; Sequeiros J; Zimmern R; Schmidtke J
    Community Genet; 2008; 11(2):75-120. PubMed ID: 18204250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quest for the perfect baby: why do Israeli women seek prenatal genetic testing?
    Remennick L
    Sociol Health Illn; 2006 Jan; 28(1):21-53. PubMed ID: 16509941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provision of genetic services in Europe: current practices and issues.
    Godard B; Kääriäinen H; Kristoffersson U; Tranebjaerg L; Coviello D; Aymé S
    Eur J Hum Genet; 2003 Dec; 11 Suppl 2():S13-48. PubMed ID: 14718937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal HIV screening in Europe: a review of policies.
    Deblonde J; Claeys P; Temmerman M
    Eur J Public Health; 2007 Oct; 17(5):414-8. PubMed ID: 17875579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for the prevention of hereditary diseases in a highly consanguineous population.
    Meyer BF
    Ann Hum Biol; 2005; 32(2):174-9. PubMed ID: 16096214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and control of thalassemia at Saraburi Regional Hospital.
    Chareonkul P; Kraisin J
    J Med Assoc Thai; 2004 Jan; 87(1):8-15. PubMed ID: 14971529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery.
    Lago EG; Neto EC; Melamed J; Rucks AP; Presotto C; Coelho JC; Parise C; Vargas PR; Goldbeck AS; Fiori RM
    Paediatr Perinat Epidemiol; 2007 Nov; 21(6):525-31. PubMed ID: 17937738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis and genetic screening--integration into prenatal care.
    Rappaport VJ
    Obstet Gynecol Clin North Am; 2008 Sep; 35(3):435-58, ix. PubMed ID: 18760229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best practices: antenatal screening for common genetic conditions other than aneuploidy.
    Ram KT; Klugman SD
    Curr Opin Obstet Gynecol; 2010 Apr; 22(2):139-45. PubMed ID: 20125016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Judaism, genetic screening and genetic therapy.
    Rosner F
    Mt Sinai J Med; 1998; 65(5-6):406-13. PubMed ID: 9844372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population genetic screening.
    Metcalfe SA; Barlow-Stewart K; Delatycki MB; Emery J
    Aust Fam Physician; 2007 Oct; 36(10):794-800. PubMed ID: 17925898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Michigan genetics plan: a report on the needs assessment process.
    Beene-Harris R; Bach JV
    Health Promot Pract; 2009 Apr; 10(2):201-9. PubMed ID: 19372281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring pregnant patients from risk countries with sickle cell disease and thalassemia. Clinical aspects, screening and prenatal diagnosis].
    Dickerhoff R; Kulozik AE; Kohne E
    Geburtshilfe Frauenheilkd; 1993 Apr; 53(4):215-21. PubMed ID: 8491363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.